Omicron SARS-CoV-2 new variant: global prevalence and biological and clinical characteristics

CONCLUSIONS: The new variant of SARS-CoV-2 has novel epidemiological and biological characteristics, making it more contagious than other variants of SARS-CoV-2. It has affected 2152 people in 57 countries in a short period of two weeks. However, the fatality rate of the SARS-CoV-2 Omicron variant has not yet been reported. The major clinical manifestations in this new variant are those of a "mild infection", including headache, body ache, muscles ache, cough, fever, generalized myalgia, and severe fatigue. It is infecting younger and middle-aged people more than previous variants. Worldwide health establishments should take immediate preventive measures to stop outbreaks of this emerging and reemerging pathogenic variant across the globe to minimize the disease burden on humanity.PMID:34982465 | DOI:10.26355/eurrev_202112_27652

Source: Pharmacological Reviews - January 4, 2022 Category: Drugs & Pharmacology Authors: S A Meo A S Meo F F Al-Jassir D C Klonoff Source Type: research